Chronic pain affects more than 50 million adults in the United States, yet for conditions like fibromyalgia, complex regional pain syndrome (CRPS), and treatment-resistant neuropathic pain, conventional medication options often fall far short of meaningful relief. Research over the past two decades has demonstrated that IV ketamine, administered at sub-anesthetic doses in a clinical setting, can interrupt the central sensitization mechanisms underlying some of the most difficult-to-treat pain syndromes. At H3O Interventional Psychiatry in Twin Falls, we evaluate patients with chronic pain conditions for IV ketamine for pain management as an off-label treatment option, serving a population across southern Idaho that has often had nowhere local to turn.
Understanding Why Ketamine May Help with Chronic Pain
Understanding why ketamine may help with chronic pain requires understanding what chronic pain actually is at the neurological level. In many persistent pain conditions — particularly fibromyalgia, CRPS, and chronic migraine — the nervous system undergoes a process called central sensitization, in which the brain and spinal cord become hyperresponsive to signals that would ordinarily not produce pain or would produce far less. The NMDA receptor, which ketamine directly targets, plays a central role in this sensitization process. By modulating NMDA receptor activity, ketamine can disrupt the wind-up phenomena that keep some patients locked in cycles of escalating pain even when the original injury or trigger has resolved. This mechanism is distinct from traditional pain medications like opioids, which work through entirely different receptor systems and carry well-documented risks of dependence and tolerance.
At H3O Interventional Psychiatry, we approach chronic pain patients with the same comprehensive evaluation framework we apply to psychiatric patients. Dr. Nicole Bartlett, DNP, PMHNP-BC, reviews each patient’s pain history, prior treatments, current medications, and medical profile before making any recommendations. Many chronic pain patients carry comorbid depression or anxiety — conditions that share neurobiological overlap with chronic pain and that can significantly amplify the experience of pain. This is one reason why an interventional psychiatry clinic is particularly well-positioned to evaluate and treat complex chronic pain: we understand the intersection of pain and mental health in ways that a purely pain-focused practice may not. We treat the whole patient, not just a single symptom cluster.
IV ketamine for chronic pain is typically administered in a similar protocol to its psychiatric applications — a series of infusions in a monitored clinical environment, with dosing and infusion rate adjusted to the specific indication and patient profile. Pain applications sometimes differ from psychiatric protocols in dosing range and session structure, and Dr. Bartlett will explain the specific protocol she recommends for your situation. Because ketamine is used off-label in both its psychiatric and pain applications, we prioritize informed consent and clear communication about what the evidence shows and what remains under ongoing investigation.
One of the significant barriers we hear from chronic pain patients in Idaho is the fragmented nature of their care. Many patients have seen primary care physicians, orthopedists, neurologists, and pain management specialists — often in different cities — and have received treatments that helped partially or temporarily before becoming inadequate. Integrating one more provider into an already complicated care picture feels exhausting, and we understand that. What we offer at H3O Interventional Psychiatry is a local, relationship-based evaluation that takes your full history seriously and communicates clearly with your existing care team rather than operating in isolation. Our psychiatric services in Twin Falls operate with extended hours Monday through Friday and serve patients from Twin Falls, Burley, Gooding, Jerome, and across the region.
A second barrier is the concern — especially valid in a community that has lived through the consequences of opioid prescribing — that ketamine is simply another addictive pain treatment dressed in new language. That concern deserves a direct response. IV ketamine for pain is administered in controlled clinical doses, in a medical setting, by a licensed provider, and is not dispensed for home use. The risk profile of clinically supervised IV ketamine is fundamentally different from opioid prescribing, and the mechanism of action is entirely different. For patients who have been through difficult conversations about opioids with prior providers, we welcome the chance to discuss the distinction openly and without pressure.
We treat conditions including fibromyalgia, CRPS, chronic migraine, and related neuropathic pain syndromes at H3O Interventional Psychiatry. Candidacy is determined individually, and we will always be honest when a patient’s clinical profile suggests that ketamine is unlikely to be helpful. Results vary by individual, and chronic pain is rarely a condition with simple or permanent solutions. What we can offer is a thorough evaluation, a thoughtful clinical recommendation, and access to a treatment option that has genuine scientific support for specific pain presentations. To learn more about how ketamine is used across mental health and pain conditions, explore our overview of ketamine treatment in Twin Falls, ID.
Frequently Asked Questions
What chronic pain conditions may respond to IV ketamine?
Research has examined IV ketamine’s off-label use for fibromyalgia, complex regional pain syndrome (CRPS), chronic migraine, and neuropathic pain syndromes. Efficacy varies considerably by condition and individual. An evaluation with Dr. Nicole Bartlett will assess whether your specific diagnosis and history make you a reasonable candidate.
Is IV ketamine for pain the same protocol as for depression?
The protocols differ somewhat — dosing ranges, infusion durations, and session schedules may be adjusted based on whether the primary indication is a psychiatric condition or a pain syndrome. Dr. Bartlett will explain the specific protocol she recommends and why.
How is IV ketamine different from opioids for chronic pain?
Ketamine and opioids work through entirely different receptor systems. Ketamine targets NMDA receptors in the glutamatergic system, while opioids target opioid receptors. IV ketamine administered in a clinical setting is not dispensed for home use and operates within a risk framework fundamentally different from opioid prescribing. Discuss with your provider how these distinctions apply to your specific situation.
Does insurance cover IV ketamine for chronic pain?
Coverage for IV ketamine in chronic pain applications is generally limited, as this is an off-label use. Some patients use health savings accounts (HSAs) or flexible spending accounts (FSAs) to cover costs. We recommend checking directly with your insurer and speaking with our team about pricing. You can also review our insurance information page for general guidance.
Can I receive ketamine for chronic pain if I also have depression or anxiety?
Yes — comorbid depression and anxiety are common in chronic pain patients, and H3O Interventional Psychiatry is specifically equipped to evaluate and address both dimensions. Dr. Bartlett will take your full clinical picture into account, including any psychiatric comorbidities, when developing your treatment plan.
Key Takeaways
- IV ketamine is used off-label for chronic pain conditions including fibromyalgia, CRPS, and neuropathic pain, targeting NMDA receptors involved in central sensitization.
- H3O Interventional Psychiatry in Twin Falls evaluates patients with chronic pain for IV ketamine, with particular expertise in patients who also carry comorbid depression or anxiety.
- The mechanism and risk profile of IV ketamine differ fundamentally from opioids; it is administered in a controlled clinical setting and not dispensed for home use.
- Results vary by individual, and candidacy is determined through a comprehensive evaluation with Dr. Nicole Bartlett.
- Southern Idaho patients no longer need to travel out of the region for this evaluation — extended hours are available Monday through Friday in Twin Falls.
Conclusion
Chronic pain that does not respond to conventional treatment is not a condition that patients should simply learn to accept, and the fact that standard options have not worked does not mean nothing will. At H3O Interventional Psychiatry, we take chronic pain seriously as a neurobiological condition that shares significant overlap with the psychiatric conditions we treat, and we evaluate patients for off-label IV ketamine with the same thoroughness and clinical honesty we bring to every evaluation. If you are in southern Idaho and living with fibromyalgia, CRPS, chronic migraine, or another persistent pain condition that has not responded adequately to prior treatment, schedule a consultation with our team and give yourself the chance to find out whether this approach might be different.
References
Sheehy KA, et al. — Subanesthetic Ketamine for Pain Management in Children and Adolescents. Paediatric Drugs. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927389/
Schwartzman RJ, et al. — Outpatient Intravenous Ketamine for the Treatment of Complex Regional Pain Syndrome. Pain Medicine. https://academic.oup.com/painmedicine/article/10/1/25/1837575
American Chronic Pain Association. https://theacpa.org/condition/ketamine/
National Institutes of Health — CRPS Fact Sheet. https://www.ninds.nih.gov/health-information/disorders/complex-regional-pain-syndrome
About Dr. Nicole Bartlett
Dr. Nicole Bartlett, DNP, PMHNP-BC, leads H3O Interventional Psychiatry in Twin Falls, Idaho, serving patients across southern Idaho who face geographic barriers to advanced psychiatric care. H3O Wellness is the only TMS provider within 120 miles and the only certified SPRAVATO® provider within 150 miles, offering TMS, SPRAVATO®, and IV ketamine under one roof for patients with treatment-resistant depression. Dr. Bartlett conducts thorough evaluations weighing each patient’s depression severity, treatment history, medical profile, and practical needs before recommending TMS, SPRAVATO®, ketamine, or combination approaches — with extended hours Monday through Friday to accommodate all schedules.
Medical Disclaimer
The content on this page is intended for educational purposes only and does not constitute medical advice. Information provided by H3O Interventional Psychiatry is not a substitute for professional medical evaluation, diagnosis, or treatment. Results vary by individual, and no outcomes are guaranteed. Always discuss with your provider before making any changes to your mental health treatment plan. If you are in pain crisis or experiencing a mental health emergency, please call 988 (Suicide and Crisis Lifeline) or go to your nearest emergency room.